Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNAseq of human cell line RPCI-WM1 comparing artificial PRDM1-targeting miRNA to non-targeting control, and comparing Tazemetostat treatment to DMSO. ChIPseq for the factors BLIMP1 and H3K27me3 in the RPCI-WM1, OPM-2 and NCI-H929 cell lines, along with ChIPseq for EZH2 in the NCI-H929 cell line.


ABSTRACT: To identify the role of BLIMP1 in Waldenström's macroglobulinemia, the PRDM1 transcript was targeted using an artificial miRNA. RNAseq was used to compare it to a non-targeting control in the RPCI-WM1 cell line. To determine the role of EZH2 in Waldenström's macroglobulinemia, the RPCI-WM1 cell line was treated with 0.3µM of the EZH2 inhibitor Tazemetostat, compared to DMSO vehicle control by RNAseq. ChIPseq was performed for the factors BLIMP1 and H3K27me3 in the RPCI-WM1, OPM-2 and NCI-H929 cell lines, along with ChIPseq for EZH2 in the NCI-H929 cell line.

INSTRUMENT(S): Illumina HiSeq 2500

ORGANISM(S): Homo sapiens

SUBMITTER: Kimberley Anderson 

PROVIDER: E-MTAB-7739 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

| PRJEB1759 | ENA
2024-01-29 | E-MTAB-13704 | biostudies-arrayexpress
2015-05-15 | E-GEOD-67053 | biostudies-arrayexpress
2021-04-22 | GSE172886 | GEO
2019-03-18 | E-MTAB-7496 | biostudies-arrayexpress
2013-10-19 | E-GEOD-49433 | biostudies-arrayexpress
2021-06-15 | GSE177781 | GEO
2021-02-27 | GSE167843 | GEO
2021-02-27 | GSE167675 | GEO
2021-02-27 | GSE167689 | GEO